Skip to main content
Top
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Research article

Modeling the Aneuploidy Control of Cancer

Authors: Yao Li, Arthur Berg, Louie R Wu, Zhong Wang, Gang Chen, Rongling Wu

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

Aneuploidy has long been recognized to be associated with cancer. A growing body of evidence suggests that tumorigenesis, the formation of new tumors, can be attributed to some extent to errors occurring at the mitotic checkpoint, a major cell cycle control mechanism that acts to prevent chromosome missegregation. However, so far no statistical model has been available quantify the role aneuploidy plays in determining cancer.

Methods

We develop a statistical model for testing the association between aneuploidy loci and cancer risk in a genome-wide association study. The model incorporates quantitative genetic principles into a mixture-model framework in which various genetic effects, including additive, dominant, imprinting, and their interactions, are estimated by implementing the EM algorithm.

Results

Under the new model, a series of hypotheses tests are formulated to explain the pattern of the genetic control of cancer through aneuploid loci. Simulation studies were performed to investigate the statistical behavior of the model.

Conclusions

The model will provide a tool for estimating the effects of genetic loci on aneuploidy abnormality in genome-wide studies of cancer cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Clarke R, Ressom HW, Wang A, Xuan J, Liu MC, Gehan EA, Wang Y: The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nature Reviews Cancer. 2008, 8: 184-194. 10.1038/nrc2294.CrossRef Clarke R, Ressom HW, Wang A, Xuan J, Liu MC, Gehan EA, Wang Y: The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nature Reviews Cancer. 2008, 8: 184-194. 10.1038/nrc2294.CrossRef
2.
go back to reference Stephens M, Balding DJ: Bayesian statistical methods for genetic association studies. Nature Reviews Genetics. 2009, 10: 681-690. 10.1038/nrg2615.CrossRefPubMed Stephens M, Balding DJ: Bayesian statistical methods for genetic association studies. Nature Reviews Genetics. 2009, 10: 681-690. 10.1038/nrg2615.CrossRefPubMed
3.
go back to reference Cookson W, Liang L, Abecasis G, Mokatt M, Lathrop M: Mapping complex disease traits with global gene expression. Nature Reviews Genetics. 2009, 10: 184-194. 10.1038/nrg2537.CrossRefPubMedPubMedCentral Cookson W, Liang L, Abecasis G, Mokatt M, Lathrop M: Mapping complex disease traits with global gene expression. Nature Reviews Genetics. 2009, 10: 184-194. 10.1038/nrg2537.CrossRefPubMedPubMedCentral
4.
go back to reference Mackay TFC, Stone EA, Ayroles JF: The genetics of quantitative traits: challenges and prospects. Nature Reviews Genetics. 2009, 10: 565-577. 10.1038/nrg2612.CrossRefPubMed Mackay TFC, Stone EA, Ayroles JF: The genetics of quantitative traits: challenges and prospects. Nature Reviews Genetics. 2009, 10: 565-577. 10.1038/nrg2612.CrossRefPubMed
6.
go back to reference Hede K: Which came first? Studies clarify role of aneuploidy in cancer. Journal of National Cancer Institute. 2005, 97 (2): 87-89. 10.1093/jnci/97.2.87.CrossRef Hede K: Which came first? Studies clarify role of aneuploidy in cancer. Journal of National Cancer Institute. 2005, 97 (2): 87-89. 10.1093/jnci/97.2.87.CrossRef
7.
go back to reference Ganem N, Storchova Z, Pellman D: Tetraploidy, aneuploidy and cancer. Current Opinion in Genetics and Development. 2007, 17 (2): 157-162. 10.1016/j.gde.2007.02.011.CrossRefPubMed Ganem N, Storchova Z, Pellman D: Tetraploidy, aneuploidy and cancer. Current Opinion in Genetics and Development. 2007, 17 (2): 157-162. 10.1016/j.gde.2007.02.011.CrossRefPubMed
8.
go back to reference Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature. 1998, 396 (6712): 643-649. 10.1038/25292.CrossRefPubMed Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature. 1998, 396 (6712): 643-649. 10.1038/25292.CrossRefPubMed
9.
go back to reference Duesberg P, Rasnick D, Li R, Winters L, Rausch C, Hehlmann R: How aneuploidy may cause cancer and genetic instability. Anticancer Research. 1999, 19 (6A): 4887-4906.PubMed Duesberg P, Rasnick D, Li R, Winters L, Rausch C, Hehlmann R: How aneuploidy may cause cancer and genetic instability. Anticancer Research. 1999, 19 (6A): 4887-4906.PubMed
10.
go back to reference Hanks S, Rahman N: Aneuploidy-concer predisposition syndromes: A new link between the mitotic spindle checkpoint and cancer. Cell Cycle. 2005, 4 (2): 225-227.CrossRefPubMed Hanks S, Rahman N: Aneuploidy-concer predisposition syndromes: A new link between the mitotic spindle checkpoint and cancer. Cell Cycle. 2005, 4 (2): 225-227.CrossRefPubMed
11.
go back to reference Stock RP, Bialy H: The sigmoidal curve of cancer. Nature Biotechnology. 2003, 21: 13-14. 10.1038/nbt0103-13.CrossRefPubMed Stock RP, Bialy H: The sigmoidal curve of cancer. Nature Biotechnology. 2003, 21: 13-14. 10.1038/nbt0103-13.CrossRefPubMed
12.
go back to reference Weaver BA, Cleveland DW: Does aneuploidy cause cancer?. Current Opinion in Cell Biology. 2006, 18 (6): 658-667. 10.1016/j.ceb.2006.10.002.CrossRefPubMed Weaver BA, Cleveland DW: Does aneuploidy cause cancer?. Current Opinion in Cell Biology. 2006, 18 (6): 658-667. 10.1016/j.ceb.2006.10.002.CrossRefPubMed
13.
14.
go back to reference Duesberg P: Chromosomal chaos and cancer. Scientifi American. 2007, 296 (5): 52-59. 10.1038/scientificamerican0507-52.CrossRef Duesberg P: Chromosomal chaos and cancer. Scientifi American. 2007, 296 (5): 52-59. 10.1038/scientificamerican0507-52.CrossRef
15.
go back to reference Kops GJ, Weaver BA, Cleveland DW: On the road to cancer: aneuploidy and the mitotic checkpoint. Nature Reviews Cancer. 2005, 5 (10): 773-785. 10.1038/nrc1714.CrossRefPubMed Kops GJ, Weaver BA, Cleveland DW: On the road to cancer: aneuploidy and the mitotic checkpoint. Nature Reviews Cancer. 2005, 5 (10): 773-785. 10.1038/nrc1714.CrossRefPubMed
16.
go back to reference Suijkerbuijk SJ, Kops GJ: Preventing aneu-ploidy: The contribution of mitotic checkpoint proteins. BBA-Reviews on Cancer. 2008, 1786: 24-31.PubMed Suijkerbuijk SJ, Kops GJ: Preventing aneu-ploidy: The contribution of mitotic checkpoint proteins. BBA-Reviews on Cancer. 2008, 1786: 24-31.PubMed
17.
go back to reference Maderspacher F: Theodor Boveri and the natural experiment. Current Biology. 2008, 18 (7): 279-286. 10.1016/j.cub.2008.02.061.CrossRef Maderspacher F: Theodor Boveri and the natural experiment. Current Biology. 2008, 18 (7): 279-286. 10.1016/j.cub.2008.02.061.CrossRef
18.
go back to reference Pulford DJ, Falls JG, Killian JK, Jirtle RL: Polymorphisms, genomic imprinting and cancer susceptibilit. Mutation Research. 1999, 436: 59-67. 10.1016/S1383-5742(98)00018-0.CrossRefPubMed Pulford DJ, Falls JG, Killian JK, Jirtle RL: Polymorphisms, genomic imprinting and cancer susceptibilit. Mutation Research. 1999, 436: 59-67. 10.1016/S1383-5742(98)00018-0.CrossRefPubMed
19.
go back to reference Jirtle RL: Genomic imprinting and cancer. Experimental Cell Ressearch. 1999, 248: 18-24. 10.1006/excr.1999.4453.CrossRef Jirtle RL: Genomic imprinting and cancer. Experimental Cell Ressearch. 1999, 248: 18-24. 10.1006/excr.1999.4453.CrossRef
Metadata
Title
Modeling the Aneuploidy Control of Cancer
Authors
Yao Li
Arthur Berg
Louie R Wu
Zhong Wang
Gang Chen
Rongling Wu
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-346

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine